Treatment response and prognosis evaluation in high‐grade glioma: an imaging review based on MRI

Q Zhou, C Xue, X Ke, J Zhou - Journal of Magnetic Resonance …, 2022 - Wiley Online Library
In recent years, the development of advanced magnetic resonance imaging (MRI)
technology and machine learning (ML) have created new tools for evaluating treatment …

[HTML][HTML] An insight into the risk factors of brain tumors and their therapeutic interventions

S Rasheed, K Rehman, MSH Akash - Biomedicine & Pharmacotherapy, 2021 - Elsevier
Brain tumors are an abnormal growth of cells in the brain, also known as multifactorial
groups of neoplasm. Incidence rates of brain tumors increase rapidly, and it has become a …

Expression and potential biomarkers of regulators for M7G RNA modification in gliomas

Z Chen, Z Zhang, W Ding, J Zhang, Z Tan, Y Mei… - Frontiers in …, 2022 - frontiersin.org
Gliomas are the most frequent primary malignant brain tumors of the central nervous system,
causing significant impairment and death. There is mounting evidence that N7 …

Glioma stem cell signature predicts the prognosis and the response to tumor treating fields treatment

B Chen, X Zhou, L Yang, H Zhou… - CNS Neuroscience …, 2022 - Wiley Online Library
Abstract Introduction Glioma stem cells (GSCs) play an important role in glioma recurrence
and chemo‐radiotherapy (CRT) resistance. Currently, there is a lack of efficient treatment …

Whole transcriptome and proteome analyses identify potential targets and mechanisms underlying tumor treating fields against glioblastoma

S Xu, C Luo, D Chen, L Tang, L Chen, Z Liu - Cell Death & Disease, 2022 - nature.com
Glioblastoma (GBM) is one of the most malignant types of brain cancer. Tumor treating fields
(TTFields) is the up-to-date treatment for GBM. However, its molecular mechanism requires …

Tumor-Treating Fields: A fourth modality in cancer treatment, new practice updates

R Arvind, SR Chandana, MJ Borad… - Critical Reviews in …, 2021 - Elsevier
Although major innovations in treatment are advancing, cancer persists as one of the
leading causes of mortality. With the rising incidence of cancer and as we treat them …

The role of graphene oxide nanocarriers in treating gliomas

B Wang, H Guo, H Xu, Y Chen, G Zhao, H Yu - Frontiers in oncology, 2022 - frontiersin.org
Gliomas are the most common primary malignant tumors of the central nervous system, and
their conventional treatment involves maximal safe surgical resection combined with …

Overexpression of NNMT in glioma aggravates tumor cell progression: an emerging therapeutic target

W Sun, Y Zou, Z Cai, J Huang, X Hong, Q Liang, W Jin - Cancers, 2022 - mdpi.com
Simple Summary Glioma is one of the most common intracranial malignancies and is
incurable due to strong aggressiveness and resistance to radiotherapy and chemotherapy …

Highlighted advances in therapies for difficult-to-treat brain tumours such as glioblastoma

N Cruz, M Herculano-Carvalho, D Roque, CC Faria… - Pharmaceutics, 2023 - mdpi.com
Glioblastoma multiforme (GBM) remains a challenging disease, as it is the most common
and deadly brain tumour in adults and has no curative solution and an overall short survival …

The role of m5C-related lncRNAs in predicting overall prognosis and regulating the lower grade glioma microenvironment

H Zhou, M Meng, Z Wang, H Zhang, L Yang, C Li… - Frontiers in …, 2022 - frontiersin.org
Glioma is the most lethal primary brain tumor with a poor prognosis and high recurrence
rate. Enormous efforts have been made to find therapeutic targets for gliomas. In the current …